| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | ovarian cancer | CTNNB1* | Ctnnb1* | 6 models | Alliance of Genome Resources | ||
| primary ovarian insufficiency 12 | SYCE1* | Syce1* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 13 | MSH5* | Msh5* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 19 | HSF2BP* | Hsf2bp* | 1 model | Alliance of Genome Resources | |||
| | dermoid cyst of ovary | FOXO3, FOXO3B | Foxo3* | 1 model | Alliance of Genome Resources | ||
| endometrial cancer | TP53 | Trp53* | 2 models | Alliance of Genome Resources | |||
| endometrial cancer | STK11 | Stk11* | 1 model | Alliance of Genome Resources | |||
| endometrial cancer | PTEN | Pten* | 3 models | Alliance of Genome Resources | |||
| endometrial cancer | ERRFI1 | Errfi1* | 2 models | Alliance of Genome Resources | |||
| endometriosis | HDAC3 | Hdac3* | 1 model | Alliance of Genome Resources | |||
| endometriosis | KRAS | Kras* | 1 model | Alliance of Genome Resources | |||
| female reproductive system disease | DEFB119 | Defb19* | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | APC | Apc* | 2 models | Alliance of Genome Resources | |||
| ovarian disease | PATL2 | Patl2* | 1 model | Alliance of Genome Resources | |||
| ovarian hyperstimulation syndrome | NR1H3 | Nr1h3* | 1 model | Alliance of Genome Resources | |||
| placental insufficiency | EMP2 | Emp2* | 1 model | Alliance of Genome Resources | |||
| polycystic ovary syndrome | AKT2 | Akt2* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency | FANCF | Fancf* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency | POLR3H | Polr3h* | 1 model | Alliance of Genome Resources | |||
| uterine cancer | HMGA1 | Hmga1*, Hmga1b | 1 model | Alliance of Genome Resources | |||
| uterine fibroid | TSC2 | Tsc2* | 1 model | Alliance of Genome Resources | |||
| | amenorrhea | FSHB* | Fshb | Alliance of Genome Resources | |||
| bacterial vaginosis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| cervical cancer | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| cervical cancer | NDUFS6* | Ndufs6, Ndufs6b | Alliance of Genome Resources | ||||
| cervical cancer | HLA-DPB1* | ||||||
| cervical cancer | IL1B* | Il1b | Alliance of Genome Resources | ||||
| cervical cancer | KMT2E* | Kmt2e | Alliance of Genome Resources | ||||
| cervical cancer | KMT2A* | Kmt2a | Alliance of Genome Resources | ||||
| cervical cancer | KDM3A* | Kdm3a | Alliance of Genome Resources | ||||
| cervical cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| cervical cancer | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| cervical cancer | CDC25A* | Cdc25a | Alliance of Genome Resources | ||||
| cervical cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| cervical cancer | CDK1* | Cdk1 | Alliance of Genome Resources | ||||
| cervical cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
| cervical cancer | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| cervical cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| cervical cancer | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| cervical cancer | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| cervical cancer | LINC00885* | ||||||
| cervical cancer | MAP2K3* | Map2k3 | Alliance of Genome Resources | ||||
| cervical cancer | TNFRSF10A*, TNFRSF10B, TNFRSF10C, TNFRSF10D | Tnfrsf10b | Alliance of Genome Resources | ||||
| cervical cancer | TNF* | Tnf | Alliance of Genome Resources | ||||
| cervical cancer | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| cervical cancer | TAP1* | Tap1 | Alliance of Genome Resources | ||||
| cervical cancer | TP73* | Trp73 | Alliance of Genome Resources | ||||
| cervical cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| cervical cancer | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
| cervical cancer | SF3B4* | Sf3b4 | Alliance of Genome Resources | ||||
| cervical cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| cervical cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| cervical cancer | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| cervical mucinous adenocarcinoma | STK11* | Stk11 | Alliance of Genome Resources | ||||
| cervix carcinoma | BAK1* | Bak1 | Alliance of Genome Resources | ||||
| cervix carcinoma | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| cervix carcinoma | ERAP1* | Erap1 | Alliance of Genome Resources | ||||
| cervix carcinoma | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
| cervix carcinoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| cervix carcinoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| cervix carcinoma | MGMT* | Mgmt | Alliance of Genome Resources | ||||
| cervix carcinoma | SPARC* | Sparc | Alliance of Genome Resources | ||||
| cervix carcinoma | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| cervix carcinoma | TSG101* | Tsg101 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | TERC* | ||||||
| cervix uteri carcinoma in situ | IL1B* | Il1b | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | THRB* | Thrb | Alliance of Genome Resources | ||||
| chorioamnionitis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| chorioamnionitis | TNF* | Tnf | Alliance of Genome Resources | ||||
| chorioamnionitis | LTA* | Lta | Alliance of Genome Resources | ||||
| choriocarcinoma | INSR* | Insr | Alliance of Genome Resources | ||||
| choriocarcinoma | IGF2* | Igf2 | Alliance of Genome Resources | ||||
| chronic cervicitis | IL32* | ||||||
| dysgerminoma | KIT* | Kit | Alliance of Genome Resources | ||||
| dysgerminoma | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | TSG101* | Tsg101 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | AXIN2* | Axin2 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | MAPK3* | Mapk3 | Alliance of Genome Resources | ||||
| endometrial cancer | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
| endometrial cancer | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| endometrial cancer | APC* | Apc | Alliance of Genome Resources | ||||
| endometrial cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| endometrial cancer | AR* | Ar | Alliance of Genome Resources | ||||
| endometrial cancer | ATM* | Atm | Alliance of Genome Resources | ||||
| endometrial cancer | BAD* | Bad | Alliance of Genome Resources | ||||
| endometrial cancer | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
| endometrial cancer | BST2* | Bst2 | Alliance of Genome Resources | ||||
| endometrial cancer | MSH6* | Msh6 | Alliance of Genome Resources | ||||
| endometrial cancer | CDC25C* | Cdc25c | Alliance of Genome Resources | ||||
| endometrial cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| endometrial cancer | MSH3* | Msh3 | Alliance of Genome Resources | ||||
| endometrial cancer | MRE11* | Mre11a | Alliance of Genome Resources | ||||
| endometrial cancer | MLH3* | Mlh3 | Alliance of Genome Resources | ||||
| endometrial cancer | MCPH1* | Mcph1 | Alliance of Genome Resources | ||||
| endometrial cancer | LTA* | Lta | Alliance of Genome Resources | ||||
| endometrial cancer | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| endometrial cancer | GHRH* | Ghrh | Alliance of Genome Resources | ||||
| endometrial cancer | EGF* | Egf | Alliance of Genome Resources | ||||
| endometrial cancer | EFEMP2* | Efemp2 | Alliance of Genome Resources | ||||
| endometrial cancer | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| endometrial cancer | CYP1A2* | Cyp1a2 | Alliance of Genome Resources | ||||
| endometrial cancer | SULT1A1*, SULT1A2, SULT1A3, SULT1A4 | Sult1a1 | Alliance of Genome Resources | ||||
| endometrial cancer | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| endometrial cancer | SOCS2* | Socs2 | Alliance of Genome Resources | ||||
| endometrial cancer | SHBG* | Shbg | Alliance of Genome Resources | ||||
| endometrial cancer | RNF43* | Rnf43 | Alliance of Genome Resources | ||||
| endometrial cancer | RAD21* | Rad21 | Alliance of Genome Resources | ||||
| endometrial cancer | POLE* | Pole | Alliance of Genome Resources | ||||
| endometrial cancer | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| endometrial cancer | COMT* | Comt | Alliance of Genome Resources | ||||
| endometrial cancer | SULT1E1* | Sult1e1 | Alliance of Genome Resources | ||||
| endometrial cancer | UGT1A1* | Ugt1a1 | Alliance of Genome Resources | ||||
| endometrial cancer | PIK3CD* | Pik3cd | Alliance of Genome Resources | ||||
| endometrial cancer | PGM1* | Pgm1 | Alliance of Genome Resources | ||||
| endometrial carcinoma | SPARC* | Sparc | Alliance of Genome Resources | ||||
| endometrial carcinoma | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
| endometrial carcinoma | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| endometrial carcinoma | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| endometrial carcinoma | POLE* | Pole | Alliance of Genome Resources | ||||
| endometrial carcinoma | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| endometrial carcinoma | MSH3* | Msh3 | Alliance of Genome Resources | ||||
| endometrial carcinoma | MIR152* | Mir152 | Alliance of Genome Resources | ||||
| endometrial carcinoma | HRAS* | Hras | Alliance of Genome Resources | ||||
| endometrial carcinoma | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| endometrial carcinoma | BRAF* | Braf | Alliance of Genome Resources | ||||
| endometrial carcinoma | APC* | Apc | Alliance of Genome Resources | ||||
| endometrial hyperplasia | KRAS* | Kras | Alliance of Genome Resources | ||||
| endometrial serous adenocarcinoma | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
| endometriosis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| endometriosis | PGR* | Pgr | 1 model | Alliance of Genome Resources | |||
| endometriosis | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
| endometriosis | ESR1* | Esr1 | Alliance of Genome Resources | ||||
| endometriosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| endometriosis | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
| enterocele | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
| fallopian tube disease | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | KHDC3L* | Khdc3 | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | MEI1* | Mei1 | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | NLRP7*, NLRP2 | Nlrp2 | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | TOP6BL* | Top6bl | Alliance of Genome Resources | ||||
| ovarian cancer | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
| ovarian cancer | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| ovarian cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| ovarian cancer | APOB* | Apob | Alliance of Genome Resources | ||||
| ovarian cancer | AURKA* | Aurka | Alliance of Genome Resources | ||||
| ovarian cancer | BARD1* | Bard1 | Alliance of Genome Resources | ||||
| ovarian cancer | BRCA1* | Brca1 | 2 models | Alliance of Genome Resources | |||
| ovarian cancer | BRCA2* | Brca2 | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
| ovarian cancer | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
| ovarian cancer | CD59* | Cd59a, Cd59b | Alliance of Genome Resources | ||||
| ovarian cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| ovarian cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| ovarian cancer | CLDN4* | Cldn4, Cldn13 | Alliance of Genome Resources | ||||
| ovarian cancer | COMT* | Comt | Alliance of Genome Resources | ||||
| ovarian cancer | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| ovarian cancer | EEF1A2* | Eef1a2 | Alliance of Genome Resources | ||||
| ovarian cancer | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
| ovarian cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
| ovarian cancer | GHRH* | Ghrh | Alliance of Genome Resources | ||||
| ovarian cancer | GSTA1*, GSTA2, GSTA3, GSTA5 | Gsta1, Gsta2, Gsta3, Gsta5, Gsta13 | Alliance of Genome Resources | ||||
| ovarian cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| ovarian cancer | HFE* | Hfe | Alliance of Genome Resources | ||||
| ovarian cancer | HMGA2* | Hmga2 | Alliance of Genome Resources | ||||
| ovarian cancer | ITGA8* | Itga8 | Alliance of Genome Resources | ||||
| ovarian cancer | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| ovarian cancer | JUP* | Jup | Alliance of Genome Resources | ||||
| ovarian cancer | LEF1* | Lef1 | Alliance of Genome Resources | ||||
| ovarian cancer | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| ovarian cancer | MIR1271* | ||||||
| ovarian cancer | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| ovarian cancer | MSLN* | Msln | Alliance of Genome Resources | ||||
| ovarian cancer | MUC16* | Muc16 | Alliance of Genome Resources | ||||
| ovarian cancer | MYO6* | Myo6 | Alliance of Genome Resources | ||||
| ovarian cancer | NBN* | Nbn | Alliance of Genome Resources | ||||
| ovarian cancer | NOD2* | Nod2 | Alliance of Genome Resources | ||||
| ovarian cancer | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| ovarian cancer | OIP5-AS1* | ||||||
| ovarian cancer | OPCML* | Opcml | Alliance of Genome Resources | ||||
| ovarian cancer | PIK3CA* | Pik3ca | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
| ovarian cancer | POT1* | Pot1a, Pot1b | Alliance of Genome Resources | ||||
| ovarian cancer | PRKCA* | Prkca | Alliance of Genome Resources | ||||
| ovarian cancer | PRKN* | Prkn | Alliance of Genome Resources | ||||
| ovarian cancer | PTEN* | Pten | 8 models | Alliance of Genome Resources | |||
| ovarian cancer | RAD51* | Rad51 | Alliance of Genome Resources | ||||
| ovarian cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| ovarian cancer | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| ovarian cancer | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
| ovarian cancer | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
| ovarian cancer | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| ovarian cancer | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| ovarian cancer | TFRC* | Tfrc | Alliance of Genome Resources | ||||
| ovarian cancer | UGT1A1* | Ugt1a1 | Alliance of Genome Resources | ||||
| ovarian cancer | WRAP53* | Wrap53 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| ovarian carcinoma | AMH* | Amh | Alliance of Genome Resources | ||||
| ovarian carcinoma | CASP6* | Casp6 | Alliance of Genome Resources | ||||
| ovarian carcinoma | SOCS2* | Socs2 | Alliance of Genome Resources | ||||
| ovarian carcinoma | STK11* | Stk11 | Alliance of Genome Resources | ||||
| ovarian carcinoma | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CYTB* | mt-Cytb | Alliance of Genome Resources | ||||
| ovarian carcinoma | MMP13* | Mmp13 | Alliance of Genome Resources | ||||
| ovarian carcinoma | MIR23B* | Mir23b | Alliance of Genome Resources | ||||
| ovarian carcinoma | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| ovarian carcinoma | L1CAM* | L1cam | Alliance of Genome Resources | ||||
| ovarian carcinoma | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CABIN1* | Cabin1 | Alliance of Genome Resources | ||||
| ovarian clear cell carcinoma | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
| ovarian endometrial cancer | ARHGEF10L* | Arhgef10l | Alliance of Genome Resources | ||||
| ovarian hyperstimulation syndrome | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
| ovarian hyperstimulation syndrome | FSHR* | Fshr | Alliance of Genome Resources | ||||
| ovarian serous carcinoma | ARHGEF10L* | Arhgef10l | Alliance of Genome Resources | ||||
| ovarian serous carcinoma | MAP2K4* | Map2k4 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | H19* | ||||||
| ovary epithelial cancer | KIF1B* | Kif1b | Alliance of Genome Resources | ||||
| ovary epithelial cancer | NME1* | Nme1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | TAB2* | Tab2 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | AKAP6* | Akap6 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | CCR3* | Ccr3 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | DAXX* | Daxx | Alliance of Genome Resources | ||||
| ovary epithelial cancer | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| ovary serous adenocarcinoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| placental abruption | PROC* | Proc | Alliance of Genome Resources | ||||
| placental insufficiency | EPO* | Epo | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | VDR* | Vdr | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | FST* | Fst | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CAPN10* | Capn10 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| premature menopause | POLG* | Polg | Alliance of Genome Resources | ||||
| preterm premature rupture of the membranes | SERPINH1* | Serpinh1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | POLG* | Polg | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | XPO5* | Xpo5 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | TP63* | Trp63 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | MSH4* | Msh4 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | MEIOB* | Meiob | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | KASH5* | Kash5 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | FANCA* | Fanca | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | DIAPH2* | Diaph2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | BMP15* | Bmp15 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | BBS9* | Bbs9 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 1 | FMR1* | Fmr1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 10 | MCM8* | Mcm8 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 11 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 14 | GDF9* | Gdf9 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 15 | FANCM* | Fancm | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 16 | BNC1* | Bnc1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 17 | XRCC2* | Xrcc2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 18 | C14orf39* | 4930447C04Rik | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 2A | DIAPH2* | Diaph2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 2B | POF1B* | Pof1b | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 3 | FOXL2* | Foxl2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 5 | NOBOX* | Nobox | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 6 | FIGLA* | Figla | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 7 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 8 | STAG3* | Stag3 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 9 | HFM1* | Hfm1 | Alliance of Genome Resources | ||||
| subserous uterine fibroid | TNRC6B* | Tnrc6b | Alliance of Genome Resources | ||||
| uterine cancer | AURKA* | Aurka | Alliance of Genome Resources | ||||
| uterine fibroid | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
| uterine fibroid | ADA* | Ada | Alliance of Genome Resources | ||||
| uterine fibroid | BET1L* | Bet1l | Alliance of Genome Resources | ||||
| uterine fibroid | IRS1* | Irs1 | Alliance of Genome Resources | ||||
| uterine fibroid | NUAK1* | Nuak1 | Alliance of Genome Resources | ||||
| uterine fibroid | GSTM5*, GSTM1 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| uterine fibroid | TNRC6B* | Tnrc6b | Alliance of Genome Resources | ||||
| uterine fibroid | DAPK1* | Dapk1 | Alliance of Genome Resources | ||||
| uterine fibroid | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
| uterine fibroid | COL4A1* | Col4a1 | Alliance of Genome Resources | ||||
| vulva cancer | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| vulva cancer | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| vulva cancer | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| vulva cancer | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| vulva squamous cell carcinoma | SFN* | Sfn | Alliance of Genome Resources | ||||
| vulvovaginal candidiasis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| dermoid cyst of ovary | Tg(Amh-SMAD2*)#Jebu | 1 model | |
| endosalpingiosis | Tg(Amh-SMAD2*)2Tkw | 1 model | |
| ovarian cancer | Tg(Amhr2-SV40TAg)1Dcco | 1 model | |
| ovarian cancer | Tg(CAG-lacZ,-SV40)#Bcv | 1 model | |
| polycystic ovary syndrome | Tg(Cyp17a1-NGF)2456Oje | 1 model | |
| uterine cancer | Tg(H2-K-Hmga1)#Lmsr | 1 model | |